We welcome Pedro Correia Canhao, who will be pursuing an industrial PhD in collaboration with the thriving biotech company SpliceBio, co-supervised by Dr. Silvia Frutos. He will be working on setting up a screening platform to increase the degradation of inteins and to enhance intracellular protein ligation for gene therapies.
